Skip to main navigation
For additional product information, please see

Product Information

  • AviseTest.com

Contact Us

  • Contact Us

Social

Exagen Diagnostics - Logo
  • About Exagen
    • Exagen Quality
    • Lab Certifications
  • Our Products
    • AVISE CTD
      • SLE & Connective Tissue Disease Test
    • AVISE Lupus
      • SLE Diagnostic Test
    • AVISE SLE Monitor
      • SLE Disease Monitoring Test
    • AVISE SLE Prognostic
      • SLE Prognostic Test
    • AVISE APS
      • Antiphospholipid Syndrome Test
    • AVISE MTX
      • Methotrexate Polyglutamate Measuring Test
    • AVISE HCQ
      • The Hydroxychloroquine (HCQ) test measuring drug levels in whole blood
    • AVISE Touch
      • Low volume specimen collection device
    • AVISE Anti-CarP
      • RA Diagnosis & Prognosis
    • AVISE PC4d
      • History of SLE Thrombosis
  • Our People
    • Leadership
    • Board of Directors
    • Careers
  • Our Science
    • CB-CAPs – Lupus Biomarkers
    • Clinical Trials
    • Research & Development
    • Publications
  • Business Development
    • Business Development
    • Partners
  • ESG
    • Corporate Governance
    • ESG Report
  • Investors

    Investor Relations

    • Investor Overview
    • Press Releases
    • Events
    • Presentations
    • Annual Report
    • SEC Filings
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Investor Contacts
    • Email Alerts
Image

Corporate Governance

Corporate Governance

Governance Documents
Corporate Governance Guidelines
Code of Conduct
Nominating and Governance Committee Charter
Audit Committee Charter
ESG Committee Charter
Compensation Committee Charter

Committees Composition

Audit Committee Compensation Committee Nominating and Governance Committee
Brian Birk Nominating and Governance Committee
Ana Hooker Compensation Committee
Wendy Johnson Audit Committee
Tina Nova Audit Committee Compensation Committee
Ebetuel (Beto) Pallares Nominating and Governance Committee
Bruce Robertson Compensation Committee Nominating and Governance Committee
Frank Stokes Audit Committee
James Tullis Compensation Committee
= Chairperson = Member
Print Page
Email Alerts
RSS Feeds
Investor Contacts
© 2023 Exagen Inc. | All Rights Reserved
SA1168

Footer

  • Terms of Use
  • Notice of Privacy Practices
  • Lab Certifications
  • Contact Us

Social

Image

© 2023 Exagen Inc. | All Rights Reserved

SA1168

Footer

  • Terms of Use
  • Notice of Privacy Practices
  • Lab Certifications
  • Contact Us

Social

Exagen Quality Seal
  • About Exagen
    • ← Back
    • Exagen Quality
    • Lab Certifications
  • Our Products
    • ← Back
    • AVISE CTD
      • ← Back
      • SLE & Connective Tissue Disease Test
    • AVISE Lupus
      • ← Back
      • SLE Diagnostic Test
    • AVISE SLE Monitor
      • ← Back
      • SLE Disease Monitoring Test
    • AVISE SLE Prognostic
      • ← Back
      • SLE Prognostic Test
    • AVISE APS
      • ← Back
      • Antiphospholipid Syndrome Test
    • AVISE MTX
      • ← Back
      • Methotrexate Polyglutamate Measuring Test
    • AVISE HCQ
      • ← Back
      • The Hydroxychloroquine (HCQ) test measuring drug levels in whole blood
    • AVISE Touch
      • ← Back
      • Low volume specimen collection device
    • AVISE Anti-CarP
      • ← Back
      • RA Diagnosis & Prognosis
    • AVISE PC4d
      • ← Back
      • History of SLE Thrombosis
  • Our People
    • ← Back
    • Leadership
    • Board of Directors
    • Careers
  • Our Science
    • ← Back
    • CB-CAPs – Lupus Biomarkers
    • Clinical Trials
    • Research & Development
    • Publications
  • Business Development
    • ← Back
    • Business Development
    • Partners
  • ESG
    • ← Back
    • Corporate Governance
    • ESG Report
  • Investors

    Investor Relations

    • ← Back
    • Investor Overview
    • Press Releases
    • Events
    • Presentations
    • Annual Report
    • SEC Filings
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Investor Contacts
    • Email Alerts